The Trend of Uro-Oncologist About Blood Test and Imaging Studies for the Diagnosis of Biochemical Recurrence in Korea.
10.22465/kjuo.2017.15.3.131
- Author:
Sung Pil SEO
1
;
Won Tae KIM
;
Ho Won KANG
;
Yong June KIM
;
Sang Cheol LEE
;
Wun Jae KIM
;
So Young KIM
;
Jong Hyock PARK
;
Seok Joong YUN
Author Information
1. Department of Urology, Chungbuk National University Hospital, Cheongju, Korea. sjyun@chungbuk.ac.kr
- Publication Type:Original Article
- Keywords:
Prostatic neoplasms;
Recurrence;
Prostate-specific antigen
- MeSH:
Diagnosis*;
Follow-Up Studies;
Hematologic Tests*;
Humans;
Insurance;
Korea*;
Magnetic Resonance Imaging;
Prostate-Specific Antigen;
Prostatectomy;
Prostatic Neoplasms;
Recurrence*;
Statistics as Topic
- From:Korean Journal of Urological Oncology
2017;15(3):131-136
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The aim of this study is to investigate the criteria of biochemical recurrence (BCR) and follow-up periods and methods with and without blood and imaging test of urologic oncology before established guidelines of prostate cancer in Korea. MATERIALS AND METHODS: In December 2015, we sent the questionnaire to urologic oncologist in academic hospital and received the answer from 108 urologic oncologist (50%). Also, we analyzed the data of 1,141 patients underwent radical prostatectomy in 2005 from Korean Medical Insurance. RESULTS: In follow-up, 72 physicians (66.7%) performed blood test every 3 months, 51 physicians (47.2%) performed imaging study in case of BCR. Bone scan was the most common imaging study in the follow-up (74 physicians, 68.5%). But, bone scan was only performed in case of BCR (43 physicians, 39.8%). The criteria of BCR was PSA 0.2 ng/mL (75 physician, 69.4%), 76 physicians (70.4%) was performed different follow-up according to risk of patients. In Korean Medical Insurance data analysis, PSA were performed average 2 times every year and magnetic resonance imaging, computed tomography, Bone scan were performed average 0.1, 0.2, 0.1 times every year, respectively. CONCLUSIONS: The criteria of BCR and the follow-up of prostate cancer patients in Korea were similar Korean prostate cancer guidelines. Blood and imaging test might be increased compared to 10 years ago, it is necessary to compare the Korean Medical Insurance data between 10 years ago and present.
